New York panel seeks extra Medicaid rebates from Biogen for pricey rare disease drug - STAT

New York panel seeks extra Medicaid rebates from Biogen for pricey rare disease drug - STAT

STAT Plus: New York panel seeks extra Medicaid rebates from Biogen for pricey rare disease drug

By ED SILVERMAN

RUBY WALLAU FOR STAT

“This process about setting concrete price targets for negotiations is now starting to now become routine,” said Steve Pearson, who heads ICER.

READ MORE